The outlook for the KLKB1 inhibitors market is increasingly positive, driven by growing recognition of the kallikrein–kinin ...

Pyrukynd, which Agios sells for a rare type of anemia, missed one of its main objectives in a study seen as crucial for its ...

Completed strategic pivot from R&D focus to commercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned ...

Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine supply chains, and TAPI ? Technology and API Services, today announced a strategic partnership. Antheia will ...

The global wine enzymes market is poised for robust growth, with an estimated valuation of USD 1.5 billion in 2025. The ...

Using CRISPR gene editing technology, researchers from Jiangnan University in China took a fungus that is already used as a ...

A team of researchers at the Broad Institute, led by gene-editing pioneer David Liu, has developed a new genome-editing ...

Profluent, a leader in frontier AI for protein design, today announced a $106 million financing co-led by Altimeter Capital ...

Olema Pharmaceuticals (OLMA) surges after Roche's breast cancer data, but caution is urged as key clinical results are ...

Ever wonder why certain dishes hit different, filling the kitchen with richer aromas and deeper flavor. Secret’s usually ...

Cassidy Bio, a biotechnology company developing the first AI-driven genomic foundation model to enhance the design of gene editing therapies, today announced its launch and the closing of an $8 ...

PERT edits the genome to permanently express a suppressor tRNA, so that cells affected by nonsense mutations can produce functional protein.